Kwality [KPL] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Kwality Pharmaceuticals Ltd.

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Kwality Pharmaceuticals Ltd. wins in 10 metrics, Divi's Laboratories Ltd. wins in 9 metrics, with 0 ties. Kwality Pharmaceuticals Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Kwality Pharmaceuticals Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 30.86 67.11 Kwality Pharmaceuticals Ltd.
Price-to-Book Ratio 6.02 10.82 Kwality Pharmaceuticals Ltd.
Debt-to-Equity Ratio 38.29 0.58 Divi's Laboratories Ltd.
PEG Ratio 0.35 4.63 Kwality Pharmaceuticals Ltd.
EV/EBITDA 17.28 48.63 Kwality Pharmaceuticals Ltd.
Profit Margin (TTM) 12.25% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 20.79% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 20.79% 29.65% Divi's Laboratories Ltd.
Return on Equity 15.19% 14.64% Kwality Pharmaceuticals Ltd.
Return on Assets (TTM) 8.91% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $277.15M $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return 159.49% 0.83% Kwality Pharmaceuticals Ltd.
Price-to-Sales Ratio (TTM) 3.78 16.18 Kwality Pharmaceuticals Ltd.
Enterprise Value $18.21B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 3.95 15.86 Kwality Pharmaceuticals Ltd.
Gross Profit Margin (TTM) 52.12% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $444 $388 Kwality Pharmaceuticals Ltd.
Earnings per Share (Diluted) $54.54 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.13 0.19 Kwality Pharmaceuticals Ltd.

Kwality Pharmaceuticals Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

KPL
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Kwality Pharmaceuticals Ltd.2.22%6.00%38.44%51.48%148.86%103.68%
Divi's Laboratories Ltd.0.67%-3.26%-1.31%2.02%1.80%2.98%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Kwality Pharmaceuticals Ltd.159.49%686.37%2,110.86%10,168.22%10,168.22%10,168.22%
Divi's Laboratories Ltd.0.83%89.86%56.44%484.44%1,625.50%9,907.51%

Performance & Financial Health Analysis: Kwality Pharmaceuticals Ltd. vs Divi's Laboratories Ltd.

MetricKPLDIVISLAB
Market Information
Market Cap i₹17.47B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i28,897253,443
90 Day Avg. Volume i30,328283,911
Last Close₹2,344.90₹6,576.50
52 Week Range₹828.80 - ₹2,389.70₹5,636.50 - ₹7,071.50
% from 52W High-1.87%-7.00%
All-Time High₹2,389.70 (Jun 01, 2026)₹7,071.50 (Jul 08, 2025)
% from All-Time High-1.87%-7.00%
Growth Metrics
Quarterly Revenue Growth0.46%0.12%
Quarterly Earnings Growth0.88%-0.01%
Financial Health
Profit Margin (TTM) i0.12%0.24%
Operating Margin (TTM) i0.21%0.30%
Return on Equity (TTM) i0.15%0.15%
Debt to Equity (MRQ) i38.290.58
Cash & Liquidity
Book Value per Share (MRQ)₹279.50₹580.95
Cash per Share (MRQ)₹32.82₹122.95
Operating Cash Flow (TTM) i₹387.34M₹19.67B
Levered Free Cash Flow (TTM) i₹398.45M₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend i₹0.00₹60.00

Valuation & Enterprise Metrics Analysis: Kwality Pharmaceuticals Ltd. vs Divi's Laboratories Ltd.

MetricKPL (Apr 24, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i30.8667.11
Forward P/E iN/A53.75
PEG Ratio i0.354.63
Price to Sales (TTM) i3.7816.18
Price to Book (MRQ) i6.0210.82
Market Capitalization
Market Capitalization i₹17.47B₹1.69T
Enterprise Value i₹18.21B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i3.9515.86
Enterprise to EBITDA i17.2848.63
Risk & Other Metrics
Beta i0.130.19
Book Value per Share (MRQ) i₹279.50₹580.95

Financial Statements Comparison: Kwality Pharmaceuticals Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricKPL (2025)DIVISLAB (2025)
Revenue/Sales i3.70B93.25B
Cost of Goods Sold i1.87B38.70B
COGS % of Revenue i50.6%41.5%
Gross Profit i1.83B54.55B
Gross Margin i49.4%58.5%
Research & Development iN/A270.00M
Operating Income (EBIT) i620.98M25.71B
Operating Margin i16.8%27.6%
EBITDA i822.79M33.19B
EBITDA Margin i22.2%35.6%
Pre-Tax Income i541.40M29.16B
Pre-Tax Income % of Revenue i14.6%31.3%
Income Tax i143.37M7.25B
Income Tax % of Revenue i3.9%7.8%
Net Income (Profit) i398.03M21.91B
Profit Margin i10.8%23.5%

Balance Sheet & Liquidity Metrics

MetricKPL (2025)DIVISLAB (2025)
Cash & Equivalents i120.20M4.15B
Total Current Assets i2.84B100.81B
Total Current Assets % of Revenue i76.7%108.1%
Total Current Liabilities i1.70B14.52B
Total Current Liabilities % of Revenue i45.8%15.6%
Long-Term Debt i151.19M20.00M
Long-Term Debt % of Revenue i4.1%0.0%
Total Shareholders Equity i2.62B149.69B
Retained Earnings i2.44B134.00B
Retained Earnings % of Revenue i66.0%143.7%
Property, Plant & Equipment i458.28M3.19B

Cash Flow Statement Comparison

MetricKPL (2025)DIVISLAB (2025)
Operating Cash Flow i387.34M19.67B
Operating Cash Flow % of Revenue i10.5%21.1%
Capital Expenditures i-232.17M-14.38B
Free Cash Flow i277.15M2.15B
FCF Margin i7.5%2.3%
Debt Repayment i-133.57MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricKPLDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i10.38M265.47M
Float Shares i2.30M117.72M
% Held by Insiders i103.85%52.04%
% Held by Institutions i0.00%28.65%
% Held by Public i-3.85%19.31%

Dividend Analysis & Yield Comparison: Kwality Pharmaceuticals Ltd. vs Divi's Laboratories Ltd.

MetricKPLDIVISLAB
Last 12-Month Dividend i₹0.00₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend i₹0.00₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends i₹0.00₹150.00
Ex-Dividend DateN/AJul 25, 2025